Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

355 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Usefulness of Combined Measurement of Surfactant Protein D, Thrombin-Antithrombin III Complex, D-Dimer, and Plasmin-α2 Plasmin Inhibitor Complex in Acute Exacerbation of Interstitial Lung Disease: A Retrospective Cohort Study.
Takeshita Y, To M, Kurosawa Y, Furusho N, Kinouchi T, Tsushima K, Tada Y, To Y, Sakao S. Takeshita Y, et al. Among authors: tsushima k. J Clin Med. 2024 Apr 21;13(8):2427. doi: 10.3390/jcm13082427. J Clin Med. 2024. PMID: 38673700 Free PMC article.
Combination therapy with predicted body weight-based dexamethasone, remdesivir, and baricitinib in patients with COVID-19 pneumonia: A single-center retrospective cohort study during 5th wave in Japan.
Hirasawa Y, Terada J, Shionoya Y, Fujikawa A, Isaka Y, Takeshita Y, Kinouchi T, Koshikawa K, Tajima H, Kinoshita T, Tada Y, Tatsumi K, Tsushima K. Hirasawa Y, et al. Among authors: tsushima k. Respir Investig. 2023 Jul;61(4):438-444. doi: 10.1016/j.resinv.2023.03.009. Epub 2023 Apr 18. Respir Investig. 2023. PMID: 37119744 Free PMC article.
Multicenter, single-blind, randomized controlled study of the efficacy and safety of favipiravir and nafamostat mesilate in patients with COVID-19 pneumonia.
Ikeda M, Okugawa S, Kashiwabara K, Moritoyo T, Kanno Y, Jubishi D, Hashimoto H, Okamoto K, Tsushima K, Uchida Y, Mitsumura T, Igari H, Tsutsumi T, Araoka H, Yatera K, Yamamoto Y, Nakamura Y, Otani A, Yamashita M, Wakimoto Y, Shinohara T, Adachi-Katayama M, Oyabu T, Kanematsu A, Harada S, Takeshita Y, Nakano Y, Miyazaki Y, Sakao S, Saito M, Ogura S, Yamasaki K, Kawasuji H, Hataji O, Inoue JI, Seto Y, Moriya K. Ikeda M, et al. Among authors: tsushima k. Int J Infect Dis. 2023 Mar;128:355-363. doi: 10.1016/j.ijid.2022.12.039. Epub 2023 Jan 4. Int J Infect Dis. 2023. PMID: 36610659 Free PMC article. Clinical Trial.
Impact of inhaled ciclesonide on asymptomatic or mild COVID-19: A randomized trial.
Terada-Hirashima J, Suzuki M, Tsujimoto Y, Hamamoto Y, Uemura Y, Tsushima K, Inoue H, Komatsu S, Saito Z, Tsuzuki R, Okamoto M, To Y, Moriya K, Yoshizawa S, Tanaka M, Muto T, Mikami A, Takasaki J, Izumi S, Ohmagari N, Hojo M, Sugiura W, Sugiyama H. Terada-Hirashima J, et al. Among authors: tsushima k. Drug Discov Ther. 2022 Nov 20;16(5):225-232. doi: 10.5582/ddt.2022.01068. Epub 2022 Oct 26. Drug Discov Ther. 2022. PMID: 36288939 Free article. Clinical Trial.
Short-term inhalation of sargramostim with concomitant high-dose steroids does not hasten recovery in moderate COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial.
Shimasaki S, Baba T, Ogura T, Akasaka K, Matsushima H, Izumi S, Takasaki J, Tsushima K, Kinouchi T, Kichikawa Y, Awashima M, Izumo T, Awano N, Nishimura N, Tazawa R, Mikami A, Kitamura N, Ishii H, Kurihara Y, Taniguchi M, Aikawa S, Okada M, Morita Y, Ishikawa Y, Ohinata A, Nakata K. Shimasaki S, et al. Among authors: tsushima k. Infect Dis (Lond). 2023 Dec;55(12):857-873. doi: 10.1080/23744235.2023.2254380. Epub 2023 Oct 6. Infect Dis (Lond). 2023. PMID: 37729076 Clinical Trial.
Choroidal metastasis of non-small cell lung cancer that responded to gefitinib.
Shimomura I, Tada Y, Miura G, Suzuki T, Matsumura T, Tsushima K, Terada J, Kurimoto R, Sakaida E, Sekine I, Takiguchi Y, Yamamoto S, Tatsumi K. Shimomura I, et al. Among authors: tsushima k. Case Rep Ophthalmol Med. 2013;2013:213124. doi: 10.1155/2013/213124. Epub 2013 Sep 12. Case Rep Ophthalmol Med. 2013. PMID: 24109538 Free PMC article.
What are the factors affecting the recovery rate of bronchoalveolar lavage fluid?
Shikano K, Abe M, Shiko Y, Tsushima K, Yoshioka K, Ishiwata T, Kawasaki T, Ikari J, Terada J, Kawasaki Y, Tatsumi K. Shikano K, et al. Among authors: tsushima k. Clin Respir J. 2022 Feb;16(2):142-151. doi: 10.1111/crj.13462. Epub 2021 Dec 6. Clin Respir J. 2022. PMID: 34761545 Free PMC article.
Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study).
Kinoshita T, Shinoda M, Nishizaki Y, Shiraki K, Hirai Y, Kichikawa Y, Tsushima K, Shinkai M, Komura N, Yoshida K, Kido Y, Kakeya H, Uemura N, Kadota J. Kinoshita T, et al. Among authors: tsushima k. BMC Med. 2022 Dec 8;20(1):478. doi: 10.1186/s12916-022-02695-5. BMC Med. 2022. PMID: 36482439 Free PMC article. No abstract available.
355 results